You are here:Home-Chemical Inhibitors & Agonists-JAK/STAT Signaling-STAT-W1046
W1046

Chemical Structure : W1046

CAS No.: 2816059-41-1

W1046 (W 1046)

Catalog No.: PC-20066Not For Human Use, Lab Use Only.

W1046 is a potent and selective STAT3 inhibitor, decreases the expression of VISTA at mRNA and protein level and inhibits proliferation and survival in AML cells.

Packing Price Stock Quantity
100 mg Get quote
250 mg Get quote
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

W1046 is a potent and selective STAT3 inhibitor, decreases the expression of VISTA at mRNA and protein level and inhibits proliferation and survival in AML cells.
W1046 occupied the pivotal core of SH2 domain and elevated thermal stability of STAT3 protein.
W1046 significantly decreased the expression of VISTA at mRNA and protein level in AML cells.
W1046 significantly inhibited AML cells with hyperactive STAT3 (MOLM-13, IC50=1.85 uM) but was lacked of sensitivity in MCF-7 cells with low STAT3 activation (IC50>15 uM) and in MOLM-13 cells with STAT3 deletion by CRISPR-Cas9.
W1046 displayed no or slight effect on the phosphorylation of STAT1, STAT5, and upstream kinase JAK2.
W1046 significantly inhibited proliferation and induced apoptosis both in AML cells lines and in primary AML patient samples.
W1046 remarkedly suppressed leukemia aggression, reduced leukemia burden and prolonged the survival of leukemia mice dosage-dependently.
Combination of VISTA mAb and STAT3 inhibitor displayed potent anti-leukemia effect in xenograft mouse models with MOLM-13-EGFP/Luc cells.

Physicochemical Properties

M.Wt 610.40
Formula C28H28BF5N2O5S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(4-(N-(4-cyclohexylbenzyl)-2-((2,3,4,5,6-pentafluoro-N-methylphenyl)sulfonamido)acetamido)phenyl)boronic acid

References

1. Mo J, et al. J Hematol Oncol. 2023 Feb 27;16(1):15.

2. Deng L, et al. Boronic acid: a novel pharmacophore targeting src homology 2 (SH2) domain of STAT3. J Med Chem, 2022.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: